IMNM
Price
$9.28
Change
-$0.23 (-2.42%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
827.8M
76 days until earnings call
VSTM
Price
$9.20
Change
-$0.05 (-0.54%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
569.29M
Interact to see
Advertisement

IMNM vs VSTM

Header iconIMNM vs VSTM Comparison
Open Charts IMNM vs VSTMBanner chart's image
Immunome
Price$9.28
Change-$0.23 (-2.42%)
Volume$13.27K
Capitalization827.8M
Verastem
Price$9.20
Change-$0.05 (-0.54%)
Volume$14.29K
Capitalization569.29M
IMNM vs VSTM Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. VSTM commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and VSTM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (IMNM: $9.51 vs. VSTM: $9.25)
Brand notoriety: IMNM and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 78% vs. VSTM: 53%
Market capitalization -- IMNM: $827.8M vs. VSTM: $569.29M
IMNM [@Biotechnology] is valued at $827.8M. VSTM’s [@Biotechnology] market capitalization is $569.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while VSTM’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 5 bearish.
  • VSTM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -7.67% price change this week, while VSTM (@Biotechnology) price change was +1.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($828M) has a higher market cap than VSTM($569M). VSTM YTD gains are higher at: 78.917 vs. IMNM (-10.452). VSTM has higher annual earnings (EBITDA): -163.52M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. VSTM (164M). IMNM has less debt than VSTM: IMNM (4.14M) vs VSTM (84.7M). IMNM has higher revenues than VSTM: IMNM (12.6M) vs VSTM (2.14M).
IMNMVSTMIMNM / VSTM
Capitalization828M569M146%
EBITDA-187.92M-163.52M115%
Gain YTD-10.45278.917-13%
P/E RatioN/AN/A-
Revenue12.6M2.14M590%
Total Cash268M164M163%
Total Debt4.14M84.7M5%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMVSTM
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
86%
Momentum
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 5 days ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
87%
Bullish Trend 5 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAGX22.87-0.12
-0.52%
Nationwide Janus Henderson Overseas A
HFECX54.52-0.30
-0.55%
Janus Henderson European Focus C
RLITX16.05-0.09
-0.56%
Lazard International Strategic Eq R6
TIGRX16.17-0.13
-0.80%
Nuveen Core Equity R6
BLYYX36.04-0.33
-0.91%
American Beacon Man Lg Cp Growth Y

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-3.94%
IDYA - IMNM
60%
Loosely correlated
-1.52%
DNTH - IMNM
55%
Loosely correlated
-5.00%
SYRE - IMNM
54%
Loosely correlated
-1.38%
RXRX - IMNM
54%
Loosely correlated
-3.39%
IPSC - IMNM
52%
Loosely correlated
-1.68%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with NKTX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
+0.22%
NKTX - VSTM
38%
Loosely correlated
-3.64%
TERN - VSTM
36%
Loosely correlated
-1.56%
SYRE - VSTM
36%
Loosely correlated
-1.38%
BEAM - VSTM
34%
Loosely correlated
-2.91%
IMNM - VSTM
33%
Loosely correlated
-3.94%
More